Full Description
In this issue of Surgical Oncology Clinics, guest editor Dr. Alex Kim brings his considerable expertise to the topic of Peritoneal Surface Malignancy. Treatment for peritoneal surface malignancy (PSM) has advanced dramatically over the past decade, and in this issue, top experts discuss key topics such as pathology, classification, imaging, and therapeutics, as well as surgical advances in colorectal, gastric, appendiceal, and gynecologic cancer peritoneal metastasis.
Contains 13 relevant, practice-oriented topics including disparities and healthcare delivery for patients with PSM; pathology and classification of PSMs; diagnostic imaging of peritoneal metastasis; diagnostic advances and novel therapeutics in peritoneal metastasis; challenges of treating PSMs; and more
Provides in-depth clinical reviews on peritoneal surface malignancy, offering actionable insights for clinical practice
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Contents
Overview: Challenges of Treating Peritoneal Surface Malignancies
Molecular and Genetic Markers of Peritoneal Metastasis
Pathology and Classification of Peritoneal Surface Malignancies
Diagnostic Advances and Novel Therapeutics in Peritoneal Metastasis
Treatment and Management of Peritoneal Spread from Appendiceal Neoplasms
Treatment and Management of Peritoneal Spread from Colorectal Cancer Peritoneal Metastasis
The Role of Prophylactic or Adjuvant Hyperthermic Intraperitoneal Therapy in Appendiceal and Colorectal Cancer Peritoneal Metastasis
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Peritoneal Metastases
Systemic Therapy and Surgical Management of Peritoneal Mesothelioma
Hyperthermic Intraperitoneal Chemotherapy in the Management of Ovarian, Fallopian Tube and Peritoneal Carcinomas
Disparities and Health Care Delivery for Patients with Peritoneal Surface Malignancy
